Citi raised the firm’s price target on iRhythm (IRTC) to $242 from $205 and keeps a Buy rating on the shares. The company reported a “beat-and-raise” Q3, says Citi, which sees additional upside in the shares.
Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on IRTC:
- iRhythm price target raised to $212 from $193 at Canaccord
- Irhythm Technologies: Strong Q3 Performance and Positive Outlook Justify Buy Rating
- Irhythm Technologies: Strong Performance and Promising Growth Potential Justify Buy Rating
- iRhythm Technologies: Strong Growth and Strategic Initiatives Justify Buy Rating
- iRhythm Technologies Reports Strong Q3 2025 Growth